Biologics are large and complex compounds derived from living organisms using techniques such as recombinant DNA or cell culture. Examples include monoclonal antibodies, hormones, vaccines, cytokines amongst others. The main applications of biologics are in treating serious diseases like cancer and autoimmune disorders – a key reason for their rising prominence in recent years.
For greater impact, patients’ preferences need to be understood and continually assessed throughout the development process of biologics.
Due to this patient-centric shift, several changes have been brought about in the way processes work, which will be briefly discussed in this insight.
Expanding market presence and maximising synergies
Through planning and due diligence to
execution and stabilisation
Understanding the levers for
successful integration
Expertly navigate the challenges and
risks
Unpick the opportunities to drive the
bottom line
Disentangling a well-established site from a complex corporate infrastructure-with stringent timelines, local compliance challenges, and a rigid transitional services agreement (TSA) in place.
Redefining strategy to make process improvements and cost savings
Expertly navigate the challenges and
risks.
Combining processes, systems and
people to deliver maximum results
Working with what you've got to make
things even better
How we streamlined and future-proofed, a soon-to-be obsolete labelling solution and a rapid client expansion across multiple new sites.
Reinventing finance to optimise processes, systems and strategies
Enhancing decision making and strategic
alignment to drive performance
Using the latest technology to drive efficiencies, innovation and operational excellence
Meeting local requirements while
delivering smooth cross-border
operations
Simplifying supply chain finance
Improving compliance accuracy and
automation using tax technology
